Perhaps the flurry of BP approvals, positive results and press have investors wondering how much of the covid pie will be left? Being an OTC with no institutional buying can't help either. Maybe some lingering doubt with a few overhyped misplays and the heavy hit pieces from a few months back. Still, with steady progress on all fronts, huge potential for many indications and at least a modest piece of covid pie in the mix, you'd think we'd be a $5 stock at least. It makes you wonder just how much an EUA would un-shackle the PPS.